Financials
- Market Capitalization 21.57 M
- Employee 24
- Founded 2005
- CEO Sabrina Martucci Johnson
- Website www.darebioscience.com
- Headquarter Delaware, United States
- FIGI BBG001J2P362
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.61
ratio cours/chiffre d'affaires
20.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4533 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.88 USD | -0.50% | +13.31% | +1.76% | +137.26% | 22.47 M USD | ||
| 4535 | RADX Radiopharm Theranostics Limited American Depositary Shares | 2.86 USD | +2.14% | -0.69% | -32.71% | -46.34% | 22.55 M USD | ||
| 4545 | LGVN Longeveron Inc. - Class A Common stock | 0.69 USD | -6.76% | -6.76% | 0.00% | +20.78% | 21.49 M USD | ||
| 4547 | GRDX GridAI Technologies Corp. - Common Stock | 3.15 USD | +5.70% | +11.31% | -29.21% | +23.53% | 20.96 M USD |